Viewing Study NCT00004902


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-01-21 @ 10:48 AM
Study NCT ID: NCT00004902
Status: COMPLETED
Last Update Posted: 2012-05-30
First Post: 2000-03-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma
Sponsor: Northwestern University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma and Plasma Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory multiple myeloma View
None stage I multiple myeloma View
None stage II multiple myeloma View
None stage III multiple myeloma View